LENZ Therapeutics, Inc. (LENZ) vs Seer, Inc. (SEER)

A side-by-side comparison of LENZ Therapeutics, Inc. and Seer, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — LENZ vs SEER

growth of $100 · dividends reinvested · last 5y
LENZ -91.4% (-38.7%/yr)SEER -93.1% (-41.4%/yr)LENZ compounded faster over this window
050100150Start $10020222023202420252026$9$7
LENZ SEER

LENZ vs SEER: by the numbers

  • •SEER is the larger company ($120M vs $119M market cap).
  • •Both run net losses; SEER's is the smaller (-490.71% vs -586.74% net margin).

Metrics side by side

Valuation

MetricLENZSEER
P/S ratio5.538.69
P/B ratio0.540.53

Profitability

MetricLENZSEER
Gross margin90.14%46.31%
Operating margin-477.46%-483.85%
Net margin-586.74%-490.71%
ROE-57.47%-30.12%
ROIC-61.84%-28.87%

Growth (annualized)

MetricLENZSEER
Revenue CAGR (5Y)N/A51.57%
Total return CAGR (5Y)-35.49%-40.97%

Frequently asked

How have LENZ and SEER total returns compared?
Over the past 5 years, LENZ delivered -35.49% and SEER delivered -40.97% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.